Open-label phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma (mRCC) Meeting Abstract
| Authors: | Agarwala, S. S.; Wang, J.; Ye, D.; Sallo, V.; Stergiopoulos, S. G.; Brechenmacher, T.; Motzer, R. J. |
| Abstract Title: | Open-label phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma (mRCC) |
| Meeting Title: | 11th International Kidney Cancer Symposium |
| Journal Title: | BJU International |
| Volume: | 110 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2012 Oct 5-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 1464-4096 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2012-01-01 |
| Start Page: | 15 |
| Language: | English |
| ACCESSION: | WOS:000308932400033 |
| PROVIDER: | wos |
| DOI: | 10.1111/j.1464-410X.2012.11532.x |
| PUBMED: | 22985275 |
| Notes: | --- - Meeting Abstract: 32 - 11th International Kidney Cancer Symposium - OCT 05-06, 2012 - Chicago, IL - "2" - SI - "Source: Wos" |
